Inspection Record

Valeo Pharma Inc — Health Canada Inspection Findings

Health CanadaInspected 2021-12-13 10 findingsLabeling and packagingStability and storageDeviation, CAPA, and investigationOther quality systemComplaint and recall handlingRegulatory reporting and change control

View the regulator's official source The source document is always the basis for judgement.

Findings

1Labeling and packaging

The positive identification of each batch of drug after the packaging and/or after it was received on the importer's premises was inadequate.

2Stability and storage

The guidelines and/or procedures were inadequate in ensuring storage and/or transportation conditions would maintain the quality and safe distribution of the drug.

3Deviation, CAPA, and investigation

Investigations into deviations, reports, and/or follow-up actions were inadequate.

4Other quality system

The system for reviewing, revising, and approving standard operating procedures was inadequate. Documents were not available in one of the official languages.

5Labeling and packaging

The written agreement for outsourcing fabrication, packaging or labelling, and/or testing activities was inadequate.

6Other quality system

The content of the batch certificate was inadequate. The availability or the content of the authentic certificate of analysis was inadequate.

7Complaint and recall handling

The assessment, recording, follow-up, and/or investigation of complaints and/or other information about potentially defective products was inadequate.

8Complaint and recall handling

The quality control department's handling of complaints and/or information received about drug quality was inadequate.

9Regulatory reporting and change control

The change control system was inadequate for ensuring changes are properly documented, evaluated, and/or approved.

10Complaint and recall handling

The written procedures for recalls were inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2021-12-13. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Valeo Pharma Inc findings history — including this company's other documents Health Canada documents, 2021 Go to Findings search